The Joint Corp.
General ticker "JYNT" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $140.5M (TTM average)
The Joint Corp. does not follow the US Stock Market performance with the rate: -17.5%.
Estimated limits based on current volatility of 3.0%: low 9.03$, high 9.58$
Factors to consider:
- Total employees count: 736 (+65.8%) as of 2024
- Top business risk factors: Strategic risks and growth management, Reputation and brand risks, Dependence on franchisees, Marketing effectiveness, Regulatory and compliance
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [6.05$, 13.12$]
- 2026-12-31 to 2027-12-31 estimated range: [5.82$, 12.71$]
Financial Metrics affecting the JYNT estimates:
- Positive: with PPE of -885.5 at the end of fiscal year the price was low
- Positive: -5.39 < Operating profit margin, % of -1.64
- Negative: Industry operating cash flow per share per price (median), % of 5.14 <= 5.46
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Negative: Industry operating profit margin (median), % of 0.04 <= 2.88
- Positive: Investing cash flow per share per price, % of 4.68 > -0.60
- Positive: -3.75 < Return on assets ratio (scaled to [-100,100]) of -0.44
- Negative: Industry earnings per price (median), % of 0 <= 0
- Negative: Operating cash flow per share per price, % of 1.37 <= 6.59
- Positive: 19.24 < Shareholder equity ratio, % of 24.69 <= 42.59
Short-term JYNT quotes
Long-term JYNT plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $46.98MM | $52.10MM | $54.89MM |
| Operating Expenses | $46.66MM | $53.99MM | $55.80MM |
| Operating Income | $0.32MM | $-1.89MM | $-0.91MM |
| Non-Operating Income | $-0.06MM | $0.28MM | $0.68MM |
| Interest Expense | $0.06MM | $0.00MM | $0.00MM |
| Income(Loss) | $0.25MM | $-1.61MM | $-0.23MM |
| Taxes | $11.02MM | $0.01MM | $0.04MM |
| Other Income(Loss) | $0.00MM | $-4.18MM | $3.18MM |
| Net Income(Loss)* | $-9.75MM | $-5.80MM | $2.91MM |
| Stockholders Equity | $24.75MM | $17.92MM | $15.05MM |
| Assets | $87.21MM | $80.42MM | $60.97MM |
| Operating Cash Flow | $14.68MM | $9.42MM | $1.84MM |
| Capital expenditure | $5.00MM | $1.19MM | $1.50MM |
| Investing Cash Flow | $-6.19MM | $-0.63MM | $6.27MM |
| Financing Cash Flow | $0.17MM | $-2.00MM | $-9.81MM |
| Earnings Per Share** | $-0.66 | $-0.39 | $0.19 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.